US Stock Market Move | The pharmaceutical sector received another round of capital switching, with GlaxoSmithKline plc Sponsored ADR (GSK.US) rising nearly 5%.

On Thursday, the pharmaceutical sector saw another round of fund switching, with GlaxoSmithKline plc Sponsored ADR (GSK.US) rising nearly 5%, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) and Sanofi Aventis (SNY.US) both rising over 3%, and Eli Lilly and Company (LLY.US) rising over 2%. Analysis points out that in the recent period, the technology sector, AI large models, and semiconductor sectors continue to adjust, and the market has serious concerns about overheated investment in AI computing power, cost control, and high valuations. Related sectors are experiencing high-level fluctuations and profit-taking, with funds shifting towards the pharmaceutical sector which has strong demand and is less affected by economic cycles.